Lineage Cell Therapeutics
LCTX
#8705
Rank
C$0.18 B
Marketcap
$0.83
Share price
-8.32%
Change (1 day)
-41.02%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -C$30.68 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$8.71 Million. In 2023 the company made an earning of -C$35.67 Million a decrease over its 2022 earnings that were of -C$32.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$30.68 Million-13.97%
2023 -C$35.67 Million9.83%
2022 -C$32.48 Million-54.24%
2021 -C$70.96 Million86.07%
2020 -C$38.14 Million-31.97%
2019 -C$56.06 Million-5.42%
2018 -C$59.27 Million1.1%
2017 -C$58.63 Million-31.06%
2016 -C$85.03 Million-10.38%
2015 -C$94.88 Million29.69%
2014 -C$73.17 Million31.68%
2013 -C$55.57 Million
2011 -C$26.97 Million89.78%
2010 -C$14.21 Million206.06%
2009 -C$4.65 Million-0.58%
2008 -C$4.67 Million164.89%
2007 -C$1.77 Million-30.22%
2006 -C$2.53 Million
2002 -C$2.94 Million-41.04%
2001 -C$4.98 Million-32.04%
2000 -C$7.33 Million-11.85%
1999 -C$8.31 Million
1997 -C$5.34 Million12.12%
1996 -C$4.76 Million106.25%
1995 -C$2.31 Million-11.11%
1994 -C$2.6 Million50%
1993 -C$1.74 Million20%
1992 -C$1.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.21 Billion 528.66%๐Ÿ‡บ๐Ÿ‡ธ USA